Dozens of special-interest groups that helped shape the 10-year, $938 billion healthcare measure over the past year are gearing up for a second wave of lobbying as the Obama administration prepares to implement the law, USA Today reports. For example, the U.S. Chamber of Commerce, which opposed the measure in Congress, is fighting to protect businesses that might be required to provide insurance. Meanwhile, drugmakers who supported the bill are monitoring how much they may have to discount prices.
